These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 11263342)
1. [TNF-alpha production and antitumor effect of rhIL-2-activated bone marrow cells]. Zhu B; Yang P; Sun B Zhonghua Xue Ye Xue Za Zhi; 1998 Nov; 19(11):581-2. PubMed ID: 11263342 [TBL] [Abstract][Full Text] [Related]
2. [Study of anti-myeloma activity of interleukin-2 activated bone marrow in vitro]. Liu W; Chen SL; Liu JW; Li X; Xia CQ; Qi M Zhonghua Xue Ye Xue Za Zhi; 2005 Apr; 26(4):205-8. PubMed ID: 15949260 [TBL] [Abstract][Full Text] [Related]
3. [Comparative study on the lysis of leukemia cells by IL-2 activated bone marrow and cord blood]. Shi X; Yu Z; Ma R Zhonghua Xue Ye Xue Za Zhi; 1997 Aug; 18(8):417-21. PubMed ID: 15625848 [TBL] [Abstract][Full Text] [Related]
5. [Autologous dendritic cells eliciting cytotoxicity of bone marrow cells against chronic granulocytic leukemia]. Chen J; Chen Z; Wei X; Zhang C Zhonghua Xue Ye Xue Za Zhi; 2001 Feb; 22(2):64-7. PubMed ID: 11877050 [TBL] [Abstract][Full Text] [Related]
6. [The killing effect of IL-2 and IFN-alpha activated bone marrow on K562 leukemic cell]. Li C; Yan W; Hao Y; Feng S; Qiu L; Liu H; Han J; Li X; Feng S Zhonghua Xue Ye Xue Za Zhi; 1997 Aug; 18(8):410-2. PubMed ID: 15625846 [TBL] [Abstract][Full Text] [Related]
7. Killing effect of interleukin-2 and interferon-alpha activated leukemic bone marrow in remission on K562 leukemic cells. Li C; Yan W; Hao Y; Han M; Qiu L; Liu H; Han J; Li X; Feng S Chin Med J (Engl); 1999 Jan; 112(1):53-5. PubMed ID: 11593642 [TBL] [Abstract][Full Text] [Related]
8. [Effects of recombinant human interleukin-10 on tumor necorsis factor-alpha-induced adventitial fibroblast proliferation in vitro]. Ouyang P; Meng SR; Liu YB; Xu DL; Lai WY; Peng LS; Xu AL Di Yi Jun Yi Da Xue Xue Bao; 2004 Jan; 24(1):50-2. PubMed ID: 14724096 [TBL] [Abstract][Full Text] [Related]
9. Identification of differentiation-inducing activity produced by human bone marrow stromal cell line LP101. Hiramoto M; Kawakami Y; Nabeshima R; Shima D; Handa H; Aizawa S Int J Mol Med; 2004 Nov; 14(5):867-72. PubMed ID: 15492858 [TBL] [Abstract][Full Text] [Related]
10. [Recombinant human interleukin-10 inhibits vascular smooth muscle cell proliferation induced by TNF-alpha]. OuYang P; Peng LS; Yang H; Wu WY; Xu AL Sheng Li Xue Bao; 2002 Feb; 54(1):79-82. PubMed ID: 11930247 [TBL] [Abstract][Full Text] [Related]
11. Role of soluble gp130 in the tumour necrosis factor-alpha expression and its production by peripheral blood mononuclear cells. Jablonskaca E; Puzewska W; Marcinczyk M; Jablonski J Mediators Inflamm; 2003 Dec; 12(6):355-9. PubMed ID: 14668095 [TBL] [Abstract][Full Text] [Related]
12. A novel approach to immunomodulation of frozen human bone marrow with interleukin-2 for clinical application. Charak BS; Areman EM; Dickerson SA; Choudhary GD; Sacher R; Kotula PL; Brown EG; Mazumdar A Bone Marrow Transplant; 1993 Feb; 11(2):147-54. PubMed ID: 8435664 [TBL] [Abstract][Full Text] [Related]
13. Dose-effect of interleukin-10 and its immunoregulatory role in Crohn's disease. Schmit A; Carol M; Robert F; Bontems P; Houben JJ; Van Gossum A; Goldman M; Mascart F Eur Cytokine Netw; 2002; 13(3):298-305. PubMed ID: 12231473 [TBL] [Abstract][Full Text] [Related]
14. Differences in proliferation of the hematopoietic cell line TF-1 and cytokine production by peripheral blood leukocytes induced by 2 naturally occurring forms of human IL-3. Schweiger A; Stern D; Lohman IC; Baldini M; Martinez FD; Halonen M J Allergy Clin Immunol; 2001 Mar; 107(3):505-10. PubMed ID: 11240952 [TBL] [Abstract][Full Text] [Related]
15. Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab. Zou J; Rudwaleit M; Brandt J; Thiel A; Braun J; Sieper J Arthritis Rheum; 2003 Mar; 48(3):780-90. PubMed ID: 12632433 [TBL] [Abstract][Full Text] [Related]
16. Excessive production of tumor necrosis factor-alpha by bone marrow T lymphocytes is essential in causing bone marrow failure in patients with aplastic anemia. Hara T; Ando K; Tsurumi H; Moriwaki H Eur J Haematol; 2004 Jul; 73(1):10-6. PubMed ID: 15182332 [TBL] [Abstract][Full Text] [Related]
17. [Tumor-suppression effect of polyactin A combined with GM-CSF, TNF-alpha and IL-4 on cord blood mononuclear cells]. Dong WJ; Hu HT; Gong HL Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 30(5):553-7. PubMed ID: 16320587 [TBL] [Abstract][Full Text] [Related]
18. [The T cells activated by dendritic cells derived from AML cells: a study of their cytotoxic effect on autologous AML cells]. Xiang B; Li SF; Zhou J; Mao YQ; Yang YM; Liu T Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):784-7. PubMed ID: 15573754 [TBL] [Abstract][Full Text] [Related]
19. Analysis of maturation states of rat bone marrow-derived dendritic cells using an improved culture technique. Grauer O; Wohlleben G; Seubert S; Weishaupt A; Kämpgen E; Gold R Histochem Cell Biol; 2002 Apr; 117(4):351-62. PubMed ID: 11976908 [TBL] [Abstract][Full Text] [Related]
20. In vitro production of tumor necrosis factor-alpha by adherent human peripheral blood mononuclear cells incubated with killed coccidioidal arthroconidia and spherules. Ampel NM Cell Immunol; 1994 Jan; 153(1):248-55. PubMed ID: 8287491 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]